Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX Project

In silico methods are increasingly being used for assessing the chemical safety of substances, as a part of integrated approaches involving in vitro and in vivo experiments. A paradigmatic example of these strategies is the eTOX project http://www.etoxproject.eu, funded by the European Innovative Me...

Full description

Bibliographic Details
Main Authors: Manuel Pastor, Jordi Quintana, Ferran Sanz
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-10-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2018.01147/full
id doaj-7074037c9e3443f28b5fa14f762e2da3
record_format Article
spelling doaj-7074037c9e3443f28b5fa14f762e2da32020-11-25T00:07:03ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-10-01910.3389/fphar.2018.01147413783Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX ProjectManuel PastorJordi QuintanaFerran SanzIn silico methods are increasingly being used for assessing the chemical safety of substances, as a part of integrated approaches involving in vitro and in vivo experiments. A paradigmatic example of these strategies is the eTOX project http://www.etoxproject.eu, funded by the European Innovative Medicines Initiative (IMI), which aimed at producing high quality predictions of in vivo toxicity of drug candidates and resulted in generating about 200 models for diverse endpoints of toxicological interest. In an industry-oriented project like eTOX, apart from the predictive quality, the models need to meet other quality parameters related to the procedures for their generation and their intended use. For example, when the models are used for predicting the properties of drug candidates, the prediction system must guarantee the complete confidentiality of the compound structures. The interface of the system must be designed to provide non-expert users all the information required to choose the models and appropriately interpret the results. Moreover, procedures like installation, maintenance, documentation, validation and versioning, which are common in software development, must be also implemented for the models and for the prediction platform in which they are implemented. In this article we describe our experience in the eTOX project and the lessons learned after 7 years of close collaboration between industrial and academic partners. We believe that some of the solutions found and the tools developed could be useful for supporting similar initiatives in the future.https://www.frontiersin.org/article/10.3389/fphar.2018.01147/fullin silico toxicologycomputational toxicologypredictive modelschemical safetydrug safetyindustrial environments
collection DOAJ
language English
format Article
sources DOAJ
author Manuel Pastor
Jordi Quintana
Ferran Sanz
spellingShingle Manuel Pastor
Jordi Quintana
Ferran Sanz
Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX Project
Frontiers in Pharmacology
in silico toxicology
computational toxicology
predictive models
chemical safety
drug safety
industrial environments
author_facet Manuel Pastor
Jordi Quintana
Ferran Sanz
author_sort Manuel Pastor
title Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX Project
title_short Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX Project
title_full Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX Project
title_fullStr Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX Project
title_full_unstemmed Development of an Infrastructure for the Prediction of Biological Endpoints in Industrial Environments. Lessons Learned at the eTOX Project
title_sort development of an infrastructure for the prediction of biological endpoints in industrial environments. lessons learned at the etox project
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2018-10-01
description In silico methods are increasingly being used for assessing the chemical safety of substances, as a part of integrated approaches involving in vitro and in vivo experiments. A paradigmatic example of these strategies is the eTOX project http://www.etoxproject.eu, funded by the European Innovative Medicines Initiative (IMI), which aimed at producing high quality predictions of in vivo toxicity of drug candidates and resulted in generating about 200 models for diverse endpoints of toxicological interest. In an industry-oriented project like eTOX, apart from the predictive quality, the models need to meet other quality parameters related to the procedures for their generation and their intended use. For example, when the models are used for predicting the properties of drug candidates, the prediction system must guarantee the complete confidentiality of the compound structures. The interface of the system must be designed to provide non-expert users all the information required to choose the models and appropriately interpret the results. Moreover, procedures like installation, maintenance, documentation, validation and versioning, which are common in software development, must be also implemented for the models and for the prediction platform in which they are implemented. In this article we describe our experience in the eTOX project and the lessons learned after 7 years of close collaboration between industrial and academic partners. We believe that some of the solutions found and the tools developed could be useful for supporting similar initiatives in the future.
topic in silico toxicology
computational toxicology
predictive models
chemical safety
drug safety
industrial environments
url https://www.frontiersin.org/article/10.3389/fphar.2018.01147/full
work_keys_str_mv AT manuelpastor developmentofaninfrastructureforthepredictionofbiologicalendpointsinindustrialenvironmentslessonslearnedattheetoxproject
AT jordiquintana developmentofaninfrastructureforthepredictionofbiologicalendpointsinindustrialenvironmentslessonslearnedattheetoxproject
AT ferransanz developmentofaninfrastructureforthepredictionofbiologicalendpointsinindustrialenvironmentslessonslearnedattheetoxproject
_version_ 1725420128343949312